Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-throughput Screening

Mostrar otras versiones (1)

The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has emphasized the urgency to develop effective therapeutics. Drug repurposing screening is regarded as one of the most practical and rapid approaches for the discovery of such...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Wei, Xu, Miao, Chen, Catherine Z., Guo, Hui, Shen, Min, Hu, Xin, Shinn, Paul, Klumpp-Thomas, Carleen, Michael, Samuel G., Zheng, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427131/
https://www.ncbi.nlm.nih.gov/pubmed/32803196
http://dx.doi.org/10.1101/2020.07.17.207019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427131/
https://www.ncbi.nlm.nih.gov/pubmed/32803196
http://dx.doi.org/10.1101/2020.07.17.207019

Ejemplares similares